Sign Up Today and Learn More About Incyclix Bio Stock
Invest in or calculate the value of your shares in Incyclix Bio or other pre-IPO companies through EquityZen's platform.
Incyclix Bio Stock
Incyclix Bio develops small molecule inhibitors of CDKs for the treatment of advanced and resistant cancers.
About Incyclix Bio Stock
Founded
2020
Headquarters
Durham, NC, US
Industries
Consumer Goods, Software, Artificial Intelligence
Incyclix Bio Press Mentions
Stay in the know about the latest news on Incyclix Bio
Incyclix Bio Expands Board of Directors with Appointment of Dr. Kimberly Blackwell
biospace • Dec 18, 2025
Incyclix Bio Expands Board of Directors with Appointment of Dr. Kimberly Blackwell
globenewswire • Dec 17, 2025
Fierce Biotech names Incyclix Bio a “Fierce 15” Biotech Company of 2025
globenewswire • Sep 22, 2025
Incyclix Bio: $11.25 Million Series B Extension Secured For Treating Resistant Cancer
pulse2 • Aug 29, 2025
Incyclix Bio Secures $11.25 Million Series B
citybiz • Aug 26, 2025
Incyclix Bio Management
Leadership team at Incyclix Bio
Board Member
Sid Subramony
Co-Founder/ Senior Vice President
John Bisi
Join now and verify your accreditation status to gain access to:
- Incyclix Bio Current Valuation
- Incyclix Bio Stock Price
- Incyclix Bio Management
- Available deals in Incyclix Bio and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Incyclix Bio Cap Table and Funding History by Share Class and Liquidity Preferences
- Incyclix Bio Revenue and Financials
- Incyclix Bio Highlights
- Incyclix Bio Business Model
- Incyclix Bio Risk Factors
- Incyclix Bio Research Report from SACRA Research
Trading Incyclix Bio Stock
How to invest in Incyclix Bio stock?
Accredited investors can buy pre-IPO stock in companies like Incyclix Bio through EquityZen funds. These investments are made available by existing Incyclix Bio shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Incyclix Bio stock?
Shareholders can sell their Incyclix Bio stock through EquityZen's private company marketplace. EquityZen's network includes over 440K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 52K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."